Leucadia National - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Leucadia National ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$76,705,654
+16525.6%
5,100,110
+12977.2%
0.62%
+20566.7%
Q4 2022$461,37039,0000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders